Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lecesne

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal De Chirurgie|January 23, 2003
[55 year-old male presenting with an abdominal mass]S Benoist, A Lecesne
Revue De Pneumologie Clinique|November 26, 1999
[The Cleopatra project]J P Lotz, A Lecesne, V Trillet-Lenoir
Cancer Genetics and Cytogenetics|May 29, 1999
Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas. A comparative genomic hybridization analysis of a series of 30 casesA Mairal, P Terrier, F Chibon, et al.
Oncology|April 15, 2000
Primary sarcomas of the central nervous systemO Merimsky, C Lepechoux, P Terrier, et al.
European Radiology|August 25, 2001
Recurrence of a primary malignant giant cell tumour of bone 14 years after initial surgeryM Merad, B Mesurolle, J M Guinebretière, et al.
Annales De Dermatologie Et De Venereologie|July 8, 1999
[Primary cutaneous leiomyosarcoma: 32 cases]S Auroy, G Contesso, A Spatz, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancerE Angevin, D Valteau-Couanet, F Farace, et al.
Seminars in Oncology|December 1, 1995
Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary resultsL Belli, T LeChevalier, M Gottfried, et al.
Current Oncology (Toronto, Ont.)|December 15, 2010
Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trialH Assi, G Missenard, P Terrier, et al.
British Journal of Cancer|September 15, 2001
Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomasI Ray-Coquard, H Ghesquière, T Bachelot, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal De Chirurgie|January 23, 2003
[55 year-old male presenting with an abdominal mass]S Benoist, A Lecesne
Revue De Pneumologie Clinique|November 26, 1999
[The Cleopatra project]J P Lotz, A Lecesne, V Trillet-Lenoir
Cancer Genetics and Cytogenetics|May 29, 1999
Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas. A comparative genomic hybridization analysis of a series of 30 casesA Mairal, P Terrier, F Chibon, et al.
Oncology|April 15, 2000
Primary sarcomas of the central nervous systemO Merimsky, C Lepechoux, P Terrier, et al.
European Radiology|August 25, 2001
Recurrence of a primary malignant giant cell tumour of bone 14 years after initial surgeryM Merad, B Mesurolle, J M Guinebretière, et al.
Annales De Dermatologie Et De Venereologie|July 8, 1999
[Primary cutaneous leiomyosarcoma: 32 cases]S Auroy, G Contesso, A Spatz, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancerE Angevin, D Valteau-Couanet, F Farace, et al.
Seminars in Oncology|December 1, 1995
Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary resultsL Belli, T LeChevalier, M Gottfried, et al.
Current Oncology (Toronto, Ont.)|December 15, 2010
Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trialH Assi, G Missenard, P Terrier, et al.
British Journal of Cancer|September 15, 2001
Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomasI Ray-Coquard, H Ghesquière, T Bachelot, et al.
Pageof 2